Thus, individuals carrying c.–2067A > C might have a high transcription level of ADAMTS1. Considering the potential negative association of c.-2067A > C with AD, it was suggested that the high-level ADAMTS1 might protect carriers to some extent against the risk of AD. Here, ADAMTS1 is linked to Alzheimer disease.